icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
Real world outcomes from NS5a treatment failures undergoing therapy with sofosbuvir/velpatasvir/voxilaprevir and sofosbuvir/glecaprevir/pibrentasvir
 
 
  Reported by Jules Levin
EASL 2019 April 10-14 Vienna
 
A. BOYLE1,2, F. MARRA1,2, R. FOX1, E. PETERS1, E. THOMSON1,3, R. GUNSON4, A BRADLEY4, S.T. BARCLAY5
1 Gartnavel General Hospital, Glasgow. 2 University of Liverpool, Liverpool.
3MRC-University of Glasgow Centre for Virus Research 4 West of
Scotland Specialist Virology Centre 5 Glasgow Royal Infirmary, Glasgow. United Kingdom

0411191

0411192

0411193

0411194

0411195